Conjugate containing cancer cell targeting molecules and preparation method and application thereof
A technology for targeting molecules and cancer cells, applied in the field of conjugates containing cancer cell targeting molecules and their preparation, can solve the problems of poor solubility, weak anti-tumor activity of GAA, and low bioavailability, and overcome the poor solubility. , Enhance the activity and targeting of anticancer drugs, and remove cancer cells
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Glycyrrhetinic acid (1.1mmole) and folic acid (1.3eq) were dissolved in anhydrous dichloromethane (30ml), under the catalysis of pyridine (0.5g) and 4-dimethylaminopyridine (0.5g), room temperature 25- React overnight at 30°C, filter, pass through a silica gel chromatography column (the elution solvent used is ethyl acetate and petroleum ether in a volume ratio (2-9):7), rotary evaporate, and dry to obtain the target compound as a white solid. Through liquid chromatography mass spectrometry and NMR analysis, the newly prepared white solid target compound is a conjugate with the structure shown in formula (I):
[0026]
Embodiment 2
[0028] In vitro anti-tumor effect evaluation of target compounds. In this example, breast cancer MCF-7, lymphoma BC-3 and liver cancer HepG2 cells were used to evaluate their efficacy, while LO2 liver cells were used to detect their toxicity.
[0029] Take the cells in the logarithmic growth phase and inoculate 4-40×10 cells according to the size of the cells 3 Each was placed on a 96-well plate, and after 24 hours of growth, the supernatant was discarded, and then administered in groups as follows: Tumor cells were set up with no drug addition group and drug addition group (concentration 1-100 μM for tumor cells, concentration 5-200 μM for LO2 cells), glycyrrhetinic acid coupled with folic acid GAA-FA (ie the target compound obtained in Example 1), glycyrrhetinic acid GAA, folic acid FA and an equimolar mixture of the two GAA+FA. Set up 4 to 6 multiple wells in each group, culture for 72 hours, discard the supernatant, add 100 μl of MTT (tetrazolium salt) serum-free culture ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


